Table 3. Final PRIMROSE models coefficients, after backwards eliminations.
PRIMROSE Lipid model | PRIMROSE BMI model | |||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
β Coefficient | HR | 95% CI | p | β Coefficient | HR | 95% CI | p | |
Gender (female v male) | −0.1795 | 0.84 | 0.72 to 0.96 | 0.02 | −0.49376 | 0.61 | 0.53 to 0.7 | <0.001 |
| ||||||||
Age, years (per log year increase) | 3.78124 | 43.87 | 34.61 to 55.61 | <0.001 | 3.50943 | 33.43 | 26.91 to 41.52 | <0.001 |
| ||||||||
SBP if no baseline anti-hypertensive use, mmHg (per 10 unit increase) | 0.07651 | 1.08 | 1.04 to 1.12 | <0.001 | 0.0893 | 1.09 | 1.05 to 1.14 | <0.001 |
SBP if baseline anti-hypertensive use, mmHg (per 10 unit increase) | −0.00316 | 1 | 0.95 to 1.05 | 0.9 | 0.0005 | 1 | 0.95 to 1.05 | >0.9 |
| ||||||||
Total cholesterol, mmol/L (per unit increase) | 0.11763 | 1.12 | 1.03 to 1.22 | 0.009 | ||||
| ||||||||
HDL cholesterol, mmol/L (per unit increase) | −0.8183 | 0.44 | 0.24 to 0.8 | 0.01 | ||||
| ||||||||
Weight, kg (per 10 unit increase) | 0.0068 | 1.01 | 0.97 to 1.05 | 0.7 | ||||
| ||||||||
Height, cm (per 10 unit increase) | −0.12413 | 0.88 | 0.81 to 0.96 | 0.004 | ||||
| ||||||||
History of Diabetes (yes v no) | 0.37734 | 1.46 | 1.2 to 1.77 | <0.001 | 0.44971 | 1.57 | 1.33 to 1.85 | <0.001 |
| ||||||||
Predominant smoking history | <0.001 | <0.001 | ||||||
Never | 0 | 1 | 0 | 1 | ||||
Ex | 0.01639 | 1.02 | 0.9 to 1.15 | 0.0738 | 1.08 | 0.96 to 1.21 | ||
Current | 0.29659 | 1.35 | 1.2 to 1.51 | 0.38081 | 1.46 | 1.32 to 1.62 | ||
| ||||||||
Calendar year at baseline (per 1 year increase) | −0.07043 | 0.93 | 0.92 to 0.95 | <0.001 | −0.07524 | 0.93 | 0.91 to 0.94 | <0.001 |
| ||||||||
Use of anti-depressants at baseline (yes v no) | 0.2104 | 1.23 | 1.12 to 1.36 | <0.001 | 0.21846 | 1.24 | 1.13 to 1.37 | <0.001 |
| ||||||||
History of heavy drinking (yes v no) | 0.41392 | 1.51 | 1.25 to 1.83 | <0.001 | 0.30721 | 1.36 | 1.15 to 1.61 | <0.001 |
| ||||||||
Townsend quintile of deprivation | 0.06 | 0.01 | ||||||
1 (= least deprived) | 0 | 1 | 0 | 1 | ||||
2 | 0.10963 | 1.12 | 0.96 to 1.29 | 0.10919 | 1.12 | 0.97 to 1.28 | ||
3 | 0.16388 | 1.18 | 1.03 to 1.35 | 0.18412 | 1.2 | 1.06 to 1.37 | ||
4 | 0.1828 | 1.2 | 1.03 to 1.4 | 0.20238 | 1.22 | 1.06 to 1.41 | ||
5 (= most deprived) | 0.22126 | 1.25 | 1.06 to 1.46 | 0.24762 | 1.28 | 1.1 to 1.49 | ||
| ||||||||
Severe mental illness diagnosis | 0.001 | 0.002 | ||||||
Schizophrenia | 0 | 1 | 0 | 1 | ||||
Bipolar disorder | 0.11177 | 1.12 | 0.99 to 1.26 | 0.0978 | 1.1 | 0.98 to 1.24 | ||
Other psychosis | 0.21004 | 1.23 | 1.1 to 1.39 | 0.19063 | 1.21 | 1.08 to 1.35 | ||
Unknown - on severe mental illness register | 0.01526 | 1.02 | 0.86 to 1.19 | −0.01138 | 0.99 | 0.85 to 1.15 | ||
| ||||||||
Use of second generation antipsychotics at baseline (yes v no) | 0.12121 | 1.13 | 0.96 to 1.32 | 0.1 | 0.17662 | 1.19 | 1.02 to 1.4 | 0.03 |
| ||||||||
Use of first generation antipsychotics at baseline (yes v no) | 0.1205 | 1.13 | 1.02 to 1.25 | 0.02 | ||||
| ||||||||
So(10) | 0.968011 | 0.951285 |
S0(10) is the predicted baseline survival at ten years for the model